XML 51 R37.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation (Tables)
 3 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule Of Share-Based Payment Award, Restricted Stock Purchase Plan, Valuation Assumptions
The assumptions used in the Monte-Carlo simulation model to value our market-based restricted stock units were as follows:
 Three Months Ended
June 30,
20242023
Risk-free interest rate4.5 %4.4 %
Expected volatility
23 - 43%
25 - 59%
Weighted-average volatility31 %39 %
Expected dividendsNoneNone
Schedule of Repurchase Agreements
The following table summarizes total shares repurchased during the three months ended June 30, 2024 and 2023:
August 2022 ProgramMay 2024 ProgramTotal
(In millions)Shares
Amount(a)
Shares
Amount(a)
SharesAmount
Three months ended June 30, 2024
1.2 $152 1.6 $223 2.8 $375 
Three months ended June 30, 2023
2.6 $325 — $— 2.6 $325 
(a)Amount excludes excise taxes. Accrued excise taxes are included in accrued and other current liabilities and additional paid-in capital on the Condensed Consolidated Balance Sheets.
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
The following table summarizes our stock option activity for the three months ended June 30, 2024:
Options
(in thousands)		Weighted-
Average
Exercise Prices		Weighted-
Average
Remaining
Contractual
Term  (in years)		Aggregate
Intrinsic Value
(in millions)
Outstanding as of March 31, 2024
12 $64.00 
Granted1 128.18 
Exercised(2)86.43 
Forfeited, cancelled or expired(1)58.76 
Outstanding as of June 30, 2024
10 $63.91 3.80$1 
Vested and expected to vest10 $63.91 3.80$1 
Exercisable as of June 30, 2024
10 $63.91 3.80$1 
The following table summarizes our restricted stock units activity for the three months ended June 30, 2024:
Restricted
Stock Units
(in thousands)		Weighted-
Average Grant
Date Fair Values
Outstanding as of March 31, 20247,480 $128.31 
Granted3,856 137.01 
Vested(2,204)130.65 
Forfeited or cancelled(135)129.29 
Outstanding as of June 30, 20248,997 $131.45 
The following table summarizes our performance-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the three months ended June 30, 2024:
Performance-
Based Restricted
Stock Units
(in thousands)		Weighted-
Average Grant
Date Fair Value
Outstanding as of March 31, 2024836 $129.60 
Granted763 137.53 
Vested(277)133.67 
Forfeited or cancelled(318)129.29 
Outstanding as of June 30, 20241,004 $134.60 
The following table summarizes our market-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the three months ended June 30, 2024:
Market-Based
Restricted  Stock
Units
(in thousands)		Weighted-
Average  Grant
Date Fair Value
Outstanding as of March 31, 2024354 $168.53 
Granted381 80.91 
Vested(25)173.25 
Forfeited or cancelled(73)173.25 
Outstanding as of June 30, 2024637 $115.43 
The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Condensed Consolidated Statements of Operations (in millions):
 Three Months Ended
June 30,
 20242023
Cost of revenue$4 $2 
Research and development101 93 
Marketing and sales12 11 
General and administrative26 24 
Stock-based compensation expense$143 $130